UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Memantine is a clinically well tolerated N-methyl- d-aspartate (NMDA) receptor antagonist—a review of preclinical data

Neuropharmacology, 1999-06, Vol.38 (6), p.735-767

1999

Volltextzugriff (PDF)

Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)

Brain research, 2002-12, Vol.958 (1), p.210-221

2002

Volltextzugriff (PDF)

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies

Neuroscience and biobehavioral reviews, 1997, Vol.21 (4), p.455-468

1997

Volltextzugriff (PDF)

Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man

Neuroscience letters, 1995-08, Vol.195 (2), p.137-139

1995

Volltextzugriff (PDF)

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

Neuropharmacology, 1995-10, Vol.34 (10), p.1239-1258

1995

Volltextzugriff (PDF)

L‐Ornithine‐L‐aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure

Hepatology (Baltimore, Md.), 1999-09, Vol.30 (3), p.636-640

1999

Volltextzugriff (PDF)

How to overcome resistance of influenza A viruses against adamantane derivatives

Antiviral research, 1998-02, Vol.37 (2), p.83-95

1998

Volltextzugriff (PDF)

Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia‐induced encephalopathy and acute hepatic encephalopathy in rats

Hepatology (Baltimore, Md.), 1997-04, Vol.25 (4), p.820-827

1997

Volltextzugriff (PDF)

Rheological behavior of star-shaped polymers

Macromolecules, 1993-07, Vol.26 (4), p.647-654

1993

Volltextzugriff (PDF)

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

Neuropharmacology, 1995-07, Vol.34 (7), p.713-721

1995

Volltextzugriff (PDF)

In Vitro and In Vivo Activities of Aminoadamantane and Aminoalkylcyclohexane Derivatives against Trypanosoma brucei

Antimicrobial Agents and Chemotherapy, 2001-05, Vol.45 (5), p.1360-1366

2001

Volltextzugriff (PDF)

Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization

The Journal of pharmacology and experimental therapeutics, 1997-12, Vol.283 (3), p.1264

1997

Volltextzugriff (PDF)

Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation

Amino acids, 2000-01, Vol.19 (1), p.157-166

2000

Volltextzugriff (PDF)

Modulation of NMDA receptors by glycine--introduction to some basic aspects and recent developments

Amino acids, 1998-03, Vol.14 (1-3), p.207-216

1998

Volltextzugriff (PDF)

Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice

Journal of Neural Transmission, 2001-01, Vol.108 (2), p.167-187

2001

Volltextzugriff (PDF)

NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization

Amino acids, 2000-01, Vol.19 (1), p.167-172

2000

Volltextzugriff (PDF)

L-ornithine-L-aspartate in experimental portal-systemic encephalopathy : Therapeutic efficacy and mechanism of action

Metabolic brain disease, 1998-06, Vol.13 (2), p.147-157

1998

Volltextzugriff (PDF)

Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats

Behavioural brain research, 2009-01, Vol.197 (1), p.90-96

2009

Volltextzugriff (PDF)

Extracellular concentrations of taurine, glutamate, and aspartate in the cerebral cortex of rats at the asymptomatic stage of thioacetamide-induced hepatic failure : Modulation by ketamine anesthesia

Neurochemical research, 2000-11, Vol.25 (11), p.1497-1502

2000

Volltextzugriff (PDF)

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action

Neurotoxicity research, 2000-06, Vol.2 (2-3), p.85-97

2000

Volltextzugriff (PDF)

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

European journal of pharmaceutics and biopharmaceutics, 2000-03, Vol.49 (2), p.103-109

2000

Volltextzugriff (PDF)

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

Journal of Neural Transmission, 1994-01, Vol.98 (1), p.57-67

1994

Volltextzugriff (PDF)

GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality

Amino acids, 1998, Vol.14 (1-3), p.235-239

1998

Volltextzugriff (PDF)

Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats

Journal of Neural Transmission, 1998-01, Vol.105 (10-12), p.1229-1236

1998

Volltextzugriff (PDF)

Glutamate in CNS disorders as a target for drug development: an update

Drug news & perspectives, 1998-11, Vol.11 (9), p.523-569

1998

Volltextzugriff (PDF)

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(234)
Mit Volltextzugriff
(268)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(279)
Deutsch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(100)
Animals
(75)
Male
(58)
Physical Sciences
(55)
Biological And Medical Sciences
(50)
Medical Sciences
(44)
Humans
(40)
Female
(39)
Chemistry
(33)
Pharmacology. Drug Treatments
(33)
Physics
(28)
Rats
(27)
Neurosciences & Neurology
(24)
Pharmacology & Pharmacy
(24)
Chemistry & Chemical Engineering
(22)
Physical Chemistry
(22)
Neurosciences
(21)
Physics, Atomic, Molecular & Chemical
(20)
Receptors, N-Methyl-D-Aspartate - Antagonists & Inhibitors
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Memantine is a clinically well tolerated N-methyl- d-aspartate (NMDA) receptor antagonist—a review of preclinical data

Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies

Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

L‐Ornithine‐L‐aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure

How to overcome resistance of influenza A viruses against adamantane derivatives

Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia‐induced encephalopathy and acute hepatic encephalopathy in rats

Rheological behavior of star-shaped polymers

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

In Vitro and In Vivo Activities of Aminoadamantane and Aminoalkylcyclohexane Derivatives against Trypanosoma brucei

Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization

Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation

Modulation of NMDA receptors by glycine--introduction to some basic aspects and recent developments

Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice

NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization

L-ornithine-L-aspartate in experimental portal-systemic encephalopathy : Therapeutic efficacy and mechanism of action

Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats

Extracellular concentrations of taurine, glutamate, and aspartate in the cerebral cortex of rats at the asymptomatic stage of thioacetamide-induced hepatic failure : Modulation by ketamine anesthesia

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality

Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats

Glutamate in CNS disorders as a target for drug development: an update

Suchergebnisse filtern